Arthritis & Rheumatology · 20 Nov 2026
Prescribing of High‐Risk Medications for Older Adults with Rheumatic Disease
Christine Anastasiou, Eric Roberts, Karen H. Costenbaderh-index 28, Rachael Stovall, Stephen Shiboski, Daniel Ciccarone, Michael A. Steinman, Gabriela Schmajuk, Jinoos Yazdanyh-index 22
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract: Background Older adults with rheumatic diseases often experience multi‐morbidity and polypharmacy, potentially increasing their risk of adverse events from high‐risk medications (HRMs). Objective Evaluate the prevalence, characterize HRM prescriptions by prescriber characteristics, and identify patient‐level factors associated with HRM prescribing among older adults with rheumatic diseases. Design National cohort study using the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) registry, linked to Medicare Parts A, B, and D. Setting Electronic health record‐based data from practices representing approximately one‐third of U.S. rheumatologists. Participants Medicare‐enrolled adults ≥65 years with ≥2 visits in 2021 at RISE participating practices and ≥2 ICD‐10 codes for selected rheumatic diseases. Measurements The primary outcome was prescription for a HRM. Logistic regression models were used to predict exposure to any HRM using generalized estimating equations to account for clustering of patients within practices. Results Among 45,455 older adults (mean age 75.8±6.4 years; 76.9% female), 13,977 (30.7%) received ≥1 HRM. Prescriptions predominantly originated from non‐rheumatology clinicians (82.3%). Common HRMs included skeletal muscle relaxants, first‐generation antihistamines, antidepressants with strong anticholinergic activity, non‐benzodiazepine benzodiazepine receptor agonist hypnotics (“Z‐drugs”), and antispasmodics. In adjusted analyses, patients with axial spondyloarthritis (OR 1.40, 95%CI 1.20‐1.62) and Sjögren's disease (OR 1.39, 95%CI 1.04‐1.86) had the highest odds of receiving a HRM compared with rheumatoid arthritis. Conclusions High‐risk medications are frequently prescribed to older adults with rheumatic diseases, exceeding the prevalence reported in the general Medicare population. These findings highlight the need for individualized medication review and enhanced cross‐specialty collaboration when managing this population.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Karen H. Costenbader has the highest h-index among the authors (28).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.